StockData
Adagene Inc. logo

Adagene Inc. (ADAG) stock

ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 5/30
$1.76−0.25 (-12.44%)

Close on Nov 20, 2026Market cap $104.25MP/E –Yield –

Adagene free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -$15.67M. The highest annual figure on record is -$14.78M in fiscal 2018.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.67M–
FY2024Dec 31, 2024-$29.73M–
FY2023Dec 31, 2023-$28.54M–
FY2022Dec 31, 2022-$49.30M–
FY2021Dec 31, 2021-$45.92M–
FY2020Dec 31, 2020-$29.46M–
FY2019Dec 31, 2019-$18.31M–
FY2018Dec 31, 2018-$14.78M–

More Adagene figures

See a number that looks wrong?